China NMPA Product Recall - Medical angiography X-ray system

Philips Medical Systems Nederland B.V. initiated a voluntary Class III recall of its medical angiography X-ray systems, as reported by Philips (China) Investment Co., Ltd. to the National Medical Products Administration (NMPA) on January 20, 2020. This recall addresses a critical software error where unsubtracted Digital Subtraction Angiography (DSA) images were inadvertently displayed when exported to an application. This issue could potentially compromise the diagnostic accuracy of the medical devices, which are vital for visualizing blood vessels and detecting abnormalities. The affected products include specific models registered under certificate numbers 20193060314, 20193060315, 20193060317, and 20193060319. While the detailed specifications and batch information are contained within an accompanying 'Medical Device Recall Event Report Form,' the Class III classification indicates that the issue, while serious, is unlikely to cause severe adverse health consequences. This action aligns with the NMPA's regulatory oversight to ensure the safety and efficacy of medical devices within China. The recall underscores the manufacturer's responsibility to correct software anomalies that could impact clinical utility and patient care.